Variation at the melanocortin 4 receptor gene and response to weight-loss interventions in the diabetes prevention program

Obesity

Volumn 21, Issue 9, 2013, Pages

  Pan, Qing ^a   Delahanty, Linda M ^b,c   Jablonski, Kathleen A ^a   Knowler, William C ^d   Kahn, Steven E ^e   Florez, Jose C ^b,c,f   Franks, Paul W ^g,h,i  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Digestive and Kidney Diseases   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^g LUND UNIVERSITY   (Sweden)

^h HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOCORTIN 4 RECEPTOR; METFORMIN; PLACEBO; TROGLITAZONE;

ADULT; ALLELE; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DIET THERAPY; DISEASE ASSOCIATION; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HUMAN; INCIDENCE; KINESIOTHERAPY; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MELANOCORTIN 4 RECEPTOR GENE; MULTICENTER STUDY (TOPIC); OBESITY; PHYSICAL ACTIVITY; PREVENTIVE MEDICINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT CHANGE; WEIGHT CONTROL; WEIGHT REDUCTION;

ADULT; ALLELES; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIET; EXERCISE; FEMALE; GENOTYPE; HUMANS; HYPOGLYCEMIC AGENTS; LIFE STYLE; LONGITUDINAL STUDIES; MALE; METFORMIN; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, MELANOCORTIN, TYPE 4; RISK; WEIGHT LOSS;

EID: 84884907373     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20459     Document Type: Article

References (28)

1. Schousboe K, Willemsen G, Kyvik KO, et al. Sex differences in heritability of BMI: a comparative study of results from twin studies in eight countries. Twin Res 2003; 6: 409-421.
2. Ramachandrappa S, Farooqi IS,. Genetic approaches to understanding human obesity. J Clin Invest 2011; 121: 2080-2086.
3. Speliotes EK, Willer CJ, Berndt SI, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010; 42: 937-948.
4. Martinelli CE, Keogh JM, Greenfield JR, et al. Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion. J Clin Endocrinol Metab 2011; 96: E181-E188.
5. Loos RJ, Lindgren CM, Li S, et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008; 40: 768-775.
6. Qi L, Kraft P, Hunter DJ, et al. The common obesity variant near MC4R gene is associated with higher intakes of total energy and dietary fat, weight change and diabetes risk in women. Hum Mol Genet 2008; 17: 3502-3508.
7. Branson R, Potoczna N, Kral JG, et al. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003; 348: 1096-1103.
8. Greenfield JR, Miller JW, Keogh JM, et al. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 2009; 360: 44-52.
9. Nogueiras R, Wiedmer P, Perez-Tilve D, et al. The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest 2007; 117: 3475-3488.
10. Renstrom F, Payne F, Nordstrom A, et al. Replication and extension of genome-wide association study results for obesity in 4923 adults from northern Sweden. Hum Mol Genet 2009; 18: 1489-1496.
11. Knowler WC, Hamman RF, Edelstein SL, et al. Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes 2005; 54: 1150-1156.
12. The Diabetes Prevention Program Research Group. The diabetes prevention program: baseline characteristics of the randomized cohort. Diabetes Care 2000; 23: 1619-1629.
13. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
14. Mayer-Davis EJ, Sparks KC, Hirst K, et al. Dietary intake in the diabetes prevention program cohort: baseline and 1-year post randomization. Ann Epidemiol 2004; 14: 763-772.
15. Kriska AM, Knowler WC, LaPorte RE, et al. Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care 1990; 13: 401-411.
16. Bray GA, Jablonski KA, Fujimoto WY, et al. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr 2008; 87: 1212-1218.
17. Delahanty LM, Pan Q, Jablonski KA, et al. Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the diabetes prevention program. Diabetes Care 2012; 35: 363-366.
18. Jablonski KA, McAteer JB, de Bakker PI, et al. Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program. Diabetes 2010; 59: 2672-2681.
19. Li J, Ji L,. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Hereditry 2005; 95: 221-227.
20. Young EH, Wareham NJ, Farooqi S, et al. The V103I polymorphism of the MC4R gene and obesity: population based studies and meta-analysis of 29 563 individuals. Int J Obes (Lond) 2007; 31: 1437-1441.
21. Edwards TL, Velez Edwards DR, Villegas R, et al. HTR1B, ADIPOR1, PPARGC1A, and CYP19A1 and obesity in a cohort of Caucasians and African Americans: an evaluation of gene-environment interactions and candidate genes. Am J Epidemiol 2012; 175: 11-21.
22. Adan RA, Tiesjema B, Hillebrand JJ, et al. The MC4 receptor and control of appetite. Br J Pharmacol 2006; 149: 815-827.
23. Huszar D, Lynch CA, Fairchild-Huntress V, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997; 88: 131-141.
24. Ste M, arie L, Miura GI, Marsh DJ, et al. A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc Natl Acad Sci USA 2000; 97: 12339-12344.
25. Marsh DJ, Hollopeter G, Huszar D, et al. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat Genet 1999; 21: 119-122.
26. Farooqi IS, Keogh JM, Yeo GS, et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003; 348: 1085-1095.
27. Thearle MS, Muller YL, Hanson RL, et al. Greater impact of melanocortin-4 receptor deficiency on rates of growth and risk of type 2 diabetes during childhood compared with adulthood in Pima Indians. Diabetes 2012; 61: 250-257.
28. Chambers JC, Elliott P, Zabaneh D, et al. Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat Genet 2008; 40: 716-718.